|1.||Kratz, Felix: 1 article (12/2008)|
|2.||Wu, George Y: 1 article (08/2006)|
|3.||Chemmanur, Annie T: 1 article (08/2006)|
08/01/2006 - "By May 2004, phase II clinical trials of Albuferon in HCV infection were underway. "
08/01/2006 - "Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human interferon alpha2b fusion protein, for the potential treatment of hepatitis C virus (HCV) infection. "